KRAS mutation testing in colorectal cancer as an example of the pathologist’s role in personalized targeted therapy: a practical approach
Polish Journal of Pathology · 2012
DOI: 10.5114/pjp.2012.31499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polish Journal of Pathology, 2012. Verfasst von Paweł Domagała und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Pomeranian Medical University, Szczecin, Poland. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 26-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Pomeranian Medical University, Szczecin, Poland.
Zitieren
APA
Domagała, P., Hybiak, J., Sulżyc-Bielicka, V., Cybulski, C., Ryś, J., & Domagała, W. (2012). KRAS mutation testing in colorectal cancer as an example of the pathologist’s role in personalized targeted therapy: a practical approach. Polish Journal of Pathology. https://doi.org/10.5114/pjp.2012.31499
Vancouver
Domagała P, Hybiak J, Sulżyc-Bielicka V, Cybulski C, Ryś J, Domagała W. KRAS mutation testing in colorectal cancer as an example of the pathologist’s role in personalized targeted therapy: a practical approach. Polish Journal of Pathology. 2012. doi:10.5114/pjp.2012.31499
BibTeX
@article{Domagaa2012,
author = {Domagała, Paweł and Hybiak, Jolanta and Sulżyc-Bielicka, Violetta and Cybulski, Cezary and Ryś, Janusz and Domagała, Wenancjusz},
title = {KRAS mutation testing in colorectal cancer as an example of the pathologist’s role in personalized targeted therapy: a practical approach},
journal = {Polish Journal of Pathology},
year = {2012},
doi = {10.5114/pjp.2012.31499}
}
EUVIMED